Advertisement

Diabetologia

, Volume 34, Issue 2, pp 93–102 | Cite as

Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type 1 (insulin-dependent) diabetic patients

  • P. Vardi
  • L. Crisa
  • R. A. Jackson
  • R. Dumont Herskowitz
  • J. I. Wolfsdorf
  • D. Einhorn
  • L. Linarelli
  • R. Dolinar
  • S. Wentworth
  • S. J. Brink
  • H. Starkman
  • J. S. Soeldner
  • G. S. Eisenbarth
Originals

Summary

We have followed-up 35 islet cell antibody-positive first degree relatives of patients with Type 1 (insulin-dependent) diabetes mellitus for an average of 1,300 days with sequential intravenous glucose tolerance tests. At the time of analysis and manuscript submission approximately half (18 of 35) had developed diabetes during follow-up. At initial intravenous glucose tolerance test, 11 had a 1+3 min insulin secretion below the first percentile of insulin secretion compared to 225 similarly studied normal control subjects. Six islet cell antibody positive relatives on follow-up developed an intravenous glucose tolerance test less than the first percentile. Fifteen out of 17 (88%) of these islet cell antibody positive relatives with secretion ever found to be below the first percentile are now overtly diabetic (positive predictive value=88%) and insulin-treated, while only 3 of 18 (17%) without an intravenous glucose tolerance test demonstrating loss of first phase insulin secretion have progressed to diabetes (with approximately 1,300 days of follow-up for both groups relative risk or odds ratio with intravenous glucose p<0.001). tolerance test ever below vs never below the first percentile=38, Intravenous glucose tolerance test response below the first percentile preceded diabetes by an average of 656 days. Even when first phase insulin secretion is below the first percentile, the absolute value of 1+3 min insulin above basal insulin correlates with the time to development of diabetes (r=0.586, p<0.001). With our current duration of follow-up, the negative predictive value (intravenous glucose tolerance test never below the first percentile) is 83%, and overall accuracy 86%. Incidence rates of diabetes development amongst our islet cell antibody positive relatives with follow-up while intravenous glucose tolerance test is below the first percentile is 0.48 per year (15 conversions to diabetes amongst 17 relatives in 30.8 patient years of follow-up) vs 0.05 per year (three diabetic patients in 55.5 patient years) with intravenous glucose tolerance test greater than the first percentile.

Key words

Intravenous glucose tolerance test islet cell antibodies prediction 

References

  1. 1.
    Gale EAM, Bottazzo GF (1986) Can we predict Type I (insulin-dependent) diabetes? In: Krall L (ed) World book of diabetes in practice. Elsevier, The Netherlands, pp 25–29Google Scholar
  2. 2.
    Srikanta S, Ganda OP, Jackson RA, Gleason RE, Kaldany A, Garovoy MR, Milford EL, Carpenter CB, Soeldner JS, Eisenbarth GS (1983) Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Int Med 99: 320–326CrossRefPubMedGoogle Scholar
  3. 3.
    Riley W, Maclaren N (1984) Islet cell antibodies are seldom transient. Lancet I: 1351–1352CrossRefGoogle Scholar
  4. 4.
    Srikanta S, Ganda OP, Jackson RA, Brink SJ, Fleischnick E, Yunis E, Alper C, Soeldner JS, Eisenbarth GS (1984) Pre-Type I diabetes: common endocrinologie course despite immunologie and immunogenetic heterogeneity. Diabetologia 27: 146–149CrossRefPubMedGoogle Scholar
  5. 5.
    Eisenbarth GS, Fleischnick E, Ganda OP, Srikanta S, Jackson RA, Brink SJ, Soeldner JS, Yunis E, Alper C (1985) Progressive autoimmune beta cell insufficiency: occurrence in the absence of high risk HLA alleles DR3, DR4. Diab Care 8: 477–480CrossRefGoogle Scholar
  6. 6.
    Srikanta S, Ganda OP, Soeldner JS, Eisenbarth GS (1985) First degree relatives of patients with Type I diabetes mellitus: islet cell antibodies and abnormal insulin secretion. N Engl J Med 313: 461–464CrossRefPubMedGoogle Scholar
  7. 7.
    Chase HP, Vass MA, Butler-Simon N, Hoops S, O'Brien D, Dobersen MJ (1987) Diagnosis of pre-Type I diabetes. J Pediatr 111: 807–812CrossRefPubMedGoogle Scholar
  8. 8.
    Riley W, Maclaren NK, Spillar R, Krischer J, Silverstein J, Malone J, Schwartz S, MacMillam D, Rotter J (1988) Predictive value of ICA for IDD and insulopenia to IV glucose. Diabetes [Woods Hole Suppl]: 20AGoogle Scholar
  9. 9.
    Bottazzo GF, Pujol-Borrell R, Gale EAM (1987) Autoimmunity and Type I diabetes: bringing the story up to date. In: Alberti K, Krall L (eds) The Diabetes Annual 3. Elsevier, The Netherlands, pp 15–38Google Scholar
  10. 10.
    Srikanta S, Rabizadeh A, Omar MAK, Eisenbarth GS (1985) Assay for islet cell antibodies: protein A — monoclonal antibody method. Diabetes 34: 300–305CrossRefPubMedGoogle Scholar
  11. 11.
    Boitard CH, Bonifacio E, Bottazzo GF, Gleichmann H, Molenaar J (1988) Immunology and Diabetes Workshop: Report of the Third International (Stage 3) Workshop on the Standardization of Cytoplasmic Islet Cell Antibodies. Diabetologia 31: 451–452CrossRefPubMedGoogle Scholar
  12. 12.
    Smith CP, Williams AJK, Thomas JM, Archibald HR, Algar VD, Bottazzo GF, Gale EAM, Savage MO (1988) The pattern of basal and stimulated insulin responses to intravenous glucose in first degree relatives of Type 1 (insulin dependent) diabetic children and unrelated adults aged 5 to 50 years. Diabetologia 31: 430–434CrossRefPubMedGoogle Scholar
  13. 13.
    Seltzer HS, Allen EW, Herron AL, Brennan MT (1967) Insulin secretion response to glycemie stimulus: relations of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46: 323CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Weir GC, Clore ET, Zmachinski CJ, Bonner-Weir S (1981) Islet secretion in a new experimental model for non-insulin dependent diabetes. Diabetes 30: 590–595CrossRefPubMedGoogle Scholar
  15. 15.
    Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS (1984) Pre-Type I diabetes: linear loss of beta cell response to intravenous glucose. Diabetes 33: 717–720CrossRefPubMedGoogle Scholar
  16. 16.
    Jackson RA, Soeldner JS, Eisenbarth GS (1989) Testing the dual parameter model for predicting time to diabetes. Clin Res 37: 57/AGoogle Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • P. Vardi
    • 1
  • L. Crisa
    • 1
  • R. A. Jackson
    • 1
  • R. Dumont Herskowitz
    • 2
    • 3
    • 4
    • 5
    • 6
  • J. I. Wolfsdorf
    • 2
    • 3
    • 4
    • 5
    • 6
  • D. Einhorn
    • 2
    • 3
    • 4
    • 5
    • 6
  • L. Linarelli
    • 2
    • 3
    • 4
    • 5
    • 6
  • R. Dolinar
    • 2
    • 3
    • 4
    • 5
    • 6
  • S. Wentworth
    • 2
    • 3
    • 4
    • 5
    • 6
  • S. J. Brink
    • 2
    • 3
    • 4
    • 5
    • 6
  • H. Starkman
    • 2
    • 3
    • 4
    • 5
    • 6
  • J. S. Soeldner
    • 2
    • 3
    • 4
    • 5
    • 6
  • G. S. Eisenbarth
    • 2
    • 3
    • 4
    • 5
    • 6
  1. 1.Joslin Diabetes CenterBrigham and Women's Hospital, New England Deaconess Hospital, and Harvard Medical SchoolBoston
  2. 2.University of CaliforniaDavis
  3. 3.Diabetes and Endocrine AssociatesSan Diego
  4. 4.Diabetes Center of ExcellenceHumana HospitalMesa
  5. 5.New England Diabetes and Endocrine CenterChestnut Hill
  6. 6.Pediatric/Adolescent Diabetes CenterMorristownUSA

Personalised recommendations